
Aspira Pathlab & Diagnostics Share Price
₹76.65 +3.65 (5%)
04 Mar, 2025 02:40
Start SIP in
ASPIRA
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
Investment Returns
- Over 1 Month + 3.64%
- Over 3 Month + 0.27%
- Over 6 Month + 136.72%
- Over 1 Year + 129.35%
Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!
Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Aspira Pathlab & Diagnostics Financials
Aspira Pathlab & Diagnostics Technicals
EMA & SMA
Current Price
₹76.65
+
3.65
(5%)

-
- Bearish Moving Average 0
-
- Bullish Moving Average 16
- 20 Day
- ₹70.20
- 50 Day
- ₹69.20
- 100 Day
- ₹63.76
- 200 Day
- ₹54.80
Resistance and Support
74.43
- R3 85.51
- R2 81.08
- R1 78.86
- S1 72.21
- S2 67.78
- S3 65.56
Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-07 | Quarterly Results | |
2024-11-12 | Quarterly Results | |
2024-08-13 | Quarterly Results | |
2024-05-28 | Audited Results | |
2024-02-13 | Quarterly Results |
Aspira Pathlab & Diagnostics F&O
About Aspira Pathlab & Diagnostics
- NSE Symbol
- ASPIRA
- BSE Symbol
- 540788
- Managing Director & CEO
- Dr. Pankaj J Shah
- ISIN
- INE500C01017
Similar Stocks to Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics FAQs
Aspira Pathlab & Diagnostics share price is ₹76 As on 04 March, 2025 | 02:26
The Market Cap of Aspira Pathlab & Diagnostics is ₹78.9 Cr As on 04 March, 2025 | 02:26
The P/E ratio of Aspira Pathlab & Diagnostics is 93.1 As on 04 March, 2025 | 02:26
The PB ratio of Aspira Pathlab & Diagnostics is 15.1 As on 04 March, 2025 | 02:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.